Cargando…
Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
Alzheimer’s disease (AD) is a severe neurodegenerative disorder of different brain regions accompanied by distresses and affecting more than 25 million people in the world. This progressive brain deterioration affects the central nervous system and has negative impacts on a patient’s daily activitie...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472022/ https://www.ncbi.nlm.nih.gov/pubmed/34577053 http://dx.doi.org/10.3390/molecules26185582 |
_version_ | 1784574621198057472 |
---|---|
author | Tamfu, Alfred Ngenge Kucukaydin, Selcuk Yeskaliyeva, Balakyz Ozturk, Mehmet Dinica, Rodica Mihaela |
author_facet | Tamfu, Alfred Ngenge Kucukaydin, Selcuk Yeskaliyeva, Balakyz Ozturk, Mehmet Dinica, Rodica Mihaela |
author_sort | Tamfu, Alfred Ngenge |
collection | PubMed |
description | Alzheimer’s disease (AD) is a severe neurodegenerative disorder of different brain regions accompanied by distresses and affecting more than 25 million people in the world. This progressive brain deterioration affects the central nervous system and has negative impacts on a patient’s daily activities such as memory impairment. The most important challenge concerning AD is the development of new drugs for long-term treatment or prevention, with lesser side effects and greater efficiency as cholinesterases inhibitors and the ability to remove amyloid-beta(Aβ) deposits and other related AD neuropathologies. Natural sources provide promising alternatives to synthetic cholinesterase inhibitors and many have been reported for alkaloids while neglecting other classes with potential cholinesterase inhibition. This review summarizes information about the therapeutic potential of small natural molecules from medicinal herbs, belonging to terpenoids, coumarins, and phenolic compounds, and others, which have gained special attention due to their specific modes of action and their advantages of low toxicity and high efficiency in the treatment of AD. Some show superior drug-like features in comparison to synthetic cholinesterase inhibitors. We expect that the listed phytoconstituents in this review will serve as promising tools and chemical scaffolds for the discovery of new potent therapeutic leads for the amelioration and treatment of Alzheimer’s disease. |
format | Online Article Text |
id | pubmed-8472022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84720222021-09-28 Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources Tamfu, Alfred Ngenge Kucukaydin, Selcuk Yeskaliyeva, Balakyz Ozturk, Mehmet Dinica, Rodica Mihaela Molecules Review Alzheimer’s disease (AD) is a severe neurodegenerative disorder of different brain regions accompanied by distresses and affecting more than 25 million people in the world. This progressive brain deterioration affects the central nervous system and has negative impacts on a patient’s daily activities such as memory impairment. The most important challenge concerning AD is the development of new drugs for long-term treatment or prevention, with lesser side effects and greater efficiency as cholinesterases inhibitors and the ability to remove amyloid-beta(Aβ) deposits and other related AD neuropathologies. Natural sources provide promising alternatives to synthetic cholinesterase inhibitors and many have been reported for alkaloids while neglecting other classes with potential cholinesterase inhibition. This review summarizes information about the therapeutic potential of small natural molecules from medicinal herbs, belonging to terpenoids, coumarins, and phenolic compounds, and others, which have gained special attention due to their specific modes of action and their advantages of low toxicity and high efficiency in the treatment of AD. Some show superior drug-like features in comparison to synthetic cholinesterase inhibitors. We expect that the listed phytoconstituents in this review will serve as promising tools and chemical scaffolds for the discovery of new potent therapeutic leads for the amelioration and treatment of Alzheimer’s disease. MDPI 2021-09-14 /pmc/articles/PMC8472022/ /pubmed/34577053 http://dx.doi.org/10.3390/molecules26185582 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tamfu, Alfred Ngenge Kucukaydin, Selcuk Yeskaliyeva, Balakyz Ozturk, Mehmet Dinica, Rodica Mihaela Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources |
title | Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources |
title_full | Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources |
title_fullStr | Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources |
title_full_unstemmed | Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources |
title_short | Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources |
title_sort | non-alkaloid cholinesterase inhibitory compounds from natural sources |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472022/ https://www.ncbi.nlm.nih.gov/pubmed/34577053 http://dx.doi.org/10.3390/molecules26185582 |
work_keys_str_mv | AT tamfualfredngenge nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources AT kucukaydinselcuk nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources AT yeskaliyevabalakyz nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources AT ozturkmehmet nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources AT dinicarodicamihaela nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources |